Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Just Released: "Protein Sciences Corporation - Product Pipeline Review - 2012"


Print article Print article
2013-01-28 06:36:04 - New Pharmaceuticals market report from Global Markets Direct: "Protein Sciences Corporation - Product Pipeline Review - 2012"

Global Market Direct's pharmaceuticals report, "Protein Sciences Corporation - Product Pipeline Review - 2012" provides data on the Protein Sciences Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Protein Sciences Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from Protein Sciences Corporation and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/530125_protein_sciences_corporation_product_ ..


Scope

* Protein Sciences Corporation - Brief Protein Sciences Corporation overview including

business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Protein Sciences Corporation human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Protein Sciences Corporation with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Protein Sciences Corporation's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to buy

* Evaluate Protein Sciences Corporation's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Protein Sciences Corporation in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Protein Sciences Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Protein Sciences Corporation.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Protein Sciences Corporation and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Protein Sciences Corporation Snapshot
Protein Sciences Corporation Overview
Key Information
Key Facts
Protein Sciences Corporation - Research and Development Overview
Key Therapeutic Areas
Protein Sciences Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Protein Sciences Corporation - Pipeline Products Glance
Protein Sciences Corporation - Late Stage Pipeline
Registration Filed Products/Combination Treatment Modalities
Protein Sciences Corporation Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Protein Sciences Corporation - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Protein Sciences Corporation - Drug Profiles
ASP-7374
Product Description
Mechanism of Action
R&D Progress
D-3252
Product Description
Mechanism of Action
R&D Progress
PanBlok
Product Description
Mechanism of Action
R&D Progress
Protein Sciences Corporation - Pipeline Products by Route of Administration
Protein Sciences Corporation - Recent Pipeline Updates
Protein Sciences Corporation - Dormant Projects
Protein Sciences Corporation - Locations And Subsidiaries
Head Office
Protein Sciences Corporation, Recent Developments
Protein Sciences Corporation- Press Release
Dec 11, 2012: Astellas And UMN Pharma Complete Administration Of Phase III Clinical Trials Of Seasonal Flu Vaccine ASP7374
Sep 10, 2012: Protein Sciences Announces Presentations Of Clinical Data On FluBlok At ICAAC
Mar 13, 2012: Astellas And UMN Pharma Report Immunogenicity And Favorable Tolerability In Phase II Clinical Trial For H5N1 Influenza Vaccine ASP7373
Oct 05, 2009: UMN Pharma Initiates Phase II Clinical Trial For Avian Influenza A (H5N1) Vaccine Manufactured From Cell-Culture, UMN-0501
Feb 13, 2009: UMN Pharma Presents Favorable Results From Phase I/II Study Of UMN-0501
Financial Deals Landscape
Protein Sciences Corporation, Deals Summary
Protein Sciences Corporation, Pharmaceuticals & Healthcare, Deal Details
Licensing Agreements
uniQure Enters Into Licensing Agreement With Protein Sciences For expresSF+ Insect Cell Technology
Merck Enters Into Licensing Agreement With Protein Sciences For expresSF+ Insect Cell Technology
Protein Sciences Expands Its Licensing Agreement With UMN Pharma For FluBlok And PanBlok
Protein Sciences Enters Into Licensing Agreement With UMN Pharma
Debt Offering
Protein Sciences Completes Private Placement Of Convertible Notes For $1 Million
Protein Sciences Completes Private Placement Of Convertible Notes For $6 Million
Asset Transactions
Emergent BioSolutions Acquires FluBlok And Related Technology Assets From Protein Sciences
Acquisition
Vaxine Announced To Acquire Protein Sciences
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Protein Sciences Corporation, Key Information
Protein Sciences Corporation, Key Facts
Protein Sciences Corporation - Pipeline by Indication, 2012

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=530125&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com